Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis

Fig. 2

hWJ-MSCs suppressed the activation of CD3+ hepatic T cells in Con A-induced fulminant hepatitis. A Schematic illustration of the experimental design. B Representative plots (left) and quantification (right) of flow cytometry analysis for CD3, CD19, F4/80 and NK1.1 expression in CD45+ liver non-parenchymal cells 24 h after Con A administration in indicated groups. C Quantification of flow cytometry analysis for CD3+CD4+ and CD3+CD8+ T cell ratio in CD45+ liver non-parenchymal cells 24 h after Con A administration in indicated groups. Data in B and C is shown as mean ± SD (n = 5–9/group) with the indicated significance (*p < 0.05, **p < 0.01)

Back to article page